BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14310666)

  • 1. [EXPERIMENTAL STUDIES ON THE DOSAGE DISTRIBUTION DURING THE USE OF SATELLITE BLENDS FROM LEAD IN TELECOBALT THERAPY].
    WEISHAAR J; WUNDER K; REUSS A
    Strahlentherapie; 1965 May; 127():53-64. PubMed ID: 14310666
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON TELECOBALT THERAPY MEASUREMENTS OF DOSE DISTRIBUTION IN COBALT-60 TELETHERAPY].
    OKAJIMA S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 May; 24():174-9. PubMed ID: 14175347
    [No Abstract]   [Full Text] [Related]  

  • 3. [A SIMPLIFIED DOSAGE CALCULATION IN TELECOBALT THERAPY].
    KRAUS W
    Radiobiol Radiother (Berl); 1964; 5():113-9. PubMed ID: 14189173
    [No Abstract]   [Full Text] [Related]  

  • 4. [FUNDAMENTAL STUDIES ON DOSE DISTRIBUTION OF TELECOBALT MOVING THERAPY].
    OHTAKE H; YANAGISAWA T; HIGUCHI K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Dec; 24():1067-72. PubMed ID: 14278338
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON DOSIMETRY FOR TELECOBALT THERAPY].
    BIRKNER R; POHLE G; PUPPE D
    Strahlentherapie; 1965 Jan; 126():1-13. PubMed ID: 14266127
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE SPATIAL DOSAGE DISTRIBUTION IN THE LARYNGEAL REGION IN PENDULUM IRRADIATION WITH TELECOBALT].
    FRANKE HD
    Strahlentherapie; 1965 Jan; 126():14-26. PubMed ID: 14266126
    [No Abstract]   [Full Text] [Related]  

  • 7. [A SLIT TYPE SCREEN FOR TELECOBALT THERAPY].
    MAEDA M; KOBAYASHI T; NAKATSUKA J; YAMADA C
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 May; 24():107-10. PubMed ID: 14175339
    [No Abstract]   [Full Text] [Related]  

  • 8. [CONTRIBUTION TO THE STUDY OF DOSIMETRY IN FIXED FIELD TELECOBALT THERAPY].
    GIAUX G; SWYNGEDAUW J; ROHART J; ROZAN R
    J Radiol Electrol Med Nucl; 1964 Oct; 45():547-60. PubMed ID: 14222932
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE STUDY OF THE DOSE TO THE VICINITY OF AIR-TISSUE AND TISSUE-AIR INTERFACES IN TELECOBALT THERAPY].
    LEGARE JM
    Acta Radiol Ther Phys Biol; 1964 Apr; 2():150-60. PubMed ID: 14229506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on telecobalt therapy. Measurements of dose distribution in conformation radiotherapy].
    Okajima S; Sakuma S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1966 Dec; 26(9):1199-207. PubMed ID: 5232745
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDY OF DOSE TO PROXIMITY OF AIR-TISSUE AND TISSUE-AIR INTERSPACES IN TELECOBALT THERAPY].
    LEGARE JM
    Acta Radiol Ther Phys Biol; 1964 Apr; 2():150-60. PubMed ID: 14162832
    [No Abstract]   [Full Text] [Related]  

  • 12. [APROPOS OF THE POSSIBILITIES OF BONE DAMAGE IN TELECOBALT THERAPY].
    SIRACKA E
    Radiobiol Radiother (Berl); 1963; 4():641-5. PubMed ID: 14124350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Special cones for a telecobalt apparatus and studies on dose distribution in the use of various satellite diaphragms].
    Weishaar J; Vogelsang B; Reuss A
    Strahlentherapie; 1967 Apr; 132(4):504-15. PubMed ID: 4967274
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE INFLUENCES OF THE STRUCTURE OF A TELECOBALT SIEVE TO INHOMOGENEITY QUOTIENT AND MEAN DEPTH DOSES].
    MAEDA M; KOBAYASHI T; NAKATSUKA J; YAMADA C; URANO M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Jul; 24():395-403. PubMed ID: 14193309
    [No Abstract]   [Full Text] [Related]  

  • 15. ON THE SPECIFICATION OF FIELD SIZE FOR TELECOBALT UNITS.
    HALL EJ
    Am J Roentgenol Radium Ther Nucl Med; 1964 Jul; 92():207-12. PubMed ID: 14176034
    [No Abstract]   [Full Text] [Related]  

  • 16. [INFLUENCE OF DOSE AND EXPOSURE ON THE SURVIVAL OF A GROUP OF LARYNGEAL CANCER PATIENTS TREATED BY TELECOBALT THERAPY].
    CLEMENT R; AMALRIC R; SANTAMARIA F; COLONNADISTRIA J
    J Radiol Electrol Med Nucl; 1964 Dec; 45():859-60. PubMed ID: 14269629
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDY OF DOSE DISTRIBUTION BY THE GRAPHIC AND DIRECT IONIMETRIC METHODS FOR PLANNING TELECOBALT THERAPY OF NEOPLASMS OF THE HEAD AND NECK].
    COOPMANSDEYOLDI G; FAVA G; NASTRI G
    Radiol Med; 1963 Nov; 49():1003-31. PubMed ID: 14121715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose distribution in telecobalt irradiation of collum carcinoma using a central lead filter].
    Frischbier HJ; Würthner K
    Strahlentherapie; 1972 Sep; 144(3):293-306. PubMed ID: 5085137
    [No Abstract]   [Full Text] [Related]  

  • 19. [STUDIES ON HOMOGENEITY OF DOSE DISTRIBUTION IN TUMOR. (3). COBALT-60 TELETHERAPY].
    YAMASHITA N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Jun; 24():310-7. PubMed ID: 14175053
    [No Abstract]   [Full Text] [Related]  

  • 20. AN ANALYSIS OF FACTORS AFFECTING OPTIMAL AXIS PLACEMENT AND 80 PER CENT ISODOSE VOLUME DIMENSIONS IN TELECOBALT ARC THERAPY.
    TURNER JE; JOHNSON RM; WHITFIELD SM
    Am J Roentgenol Radium Ther Nucl Med; 1965 Aug; 94():852-64. PubMed ID: 14320790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.